» » »

Molecule Helps Leukemia Cells Hide from Immune System Boston MA

The cells co-opt a protective molecular badge that is used by normal blood stem cells, and this badge helps them travel throughout the body undetected, the investigators found.

Therese M Mulvey, MD
(617) 479-3550
10 Willard St
Quincy, MA
Business
Commonwealth Physicians Services Inc
Specialties
Oncology

Data Provided by:
Eloisa V Falzarano, MD
(617) 524-1968
755 Washington St # 286
Boston, MA
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1999

Data Provided by:
Geoffrey Winglynn Chan, MD
750 Washington St # 245
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Brown Univ Program In Med, Providence Ri 02912
Graduation Year: 1996

Data Provided by:
Ronald Wayne Takvorian, MD
55 Fruit St
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Stanford Univ Sch Of Med, Stanford Ca 94305
Graduation Year: 1974

Data Provided by:
William Upjohn Shipley, MD
(617) 726-8146
100 Blossom St # 347
Boston, MA
Specialties
Oncology (Cancer), Radiation Oncology, General Surgery
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1966

Data Provided by:
Karen Kuhn Ballen
(617) 724-1124
55 Fruit St
Boston, MA
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Yoriko Saito, MD
(617) 632-3000
100 Blossom St
Boston, MA
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1995

Data Provided by:
Katherina Zabicki, MD
(617) 724-1074
48 Irving St Apt B
Boston, MA
Gender
Female
Education
Medical School: Wayne State University School Of Medicine, Detroit Mi 48201
Graduation Year: 1999

Data Provided by:
Yen-Lin E Chen
(617) 724-1160
100 Blossom Street Cox Ll
Boston, MA
Specialty
Radiation Oncology

Data Provided by:
Wb Younger
(617) 726-8698
55 Fruit St
Boston, MA
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Molecule Helps Leukemia Cells Hide from Immune System

Provided By:

Leukemia stem cells cleverly cloak themselves to avoid detection by a person's immune system, according to a pair of studies by researchers at Stanford University Medical School.

The cells co-opt a protective molecular badge that is used by normal blood stem cells, and this badge helps them travel throughout the body undetected, the investigators found.

Patients who had cancer stem cells with higher levels of this molecule have a poorer prognosis than those whose cells express lower levels, the researchers report in the July 24 issue of the journal Cell.

"We call it the 'Don't eat me signal,'" said Dr. Ravindra Majeti, assistant professor of hematology at Stanford, co-first author of the studies, which focused on acute myeloid leukemia.

"When we blocked this signal in mice with established human leukemia, the cancer cells were more easily removed by the body's natural defenses," Majeti said in a news release from Stanford.

The study findings show that the molecule could be a prognostic factor and a valuable therapeutic target for treatment of the malignancy.

The researchers found that the molecule, CD47, protects the leukemia stem cells from macrophages by binding to a molecule on the macrophage's surface. The macrophages are part of a group of cells that travel around in an effort to find and engulf diseased or dying cells. The interaction between the two proteins gets in the way of the macrophage's instinct to kill and allows the cancer cells to escape.

In the study, the high-CD47-expressing cancer stem cells were put in a culture dish with an antibody that blocks the interaction of the cancer cells with macrophages, essentially hiding the protective badge. This allowed the macrophages to "see" and engulf the cancer cells. In the study in mice, a similar treatment prevented human cancer cells from causing leukemia in the animals, and even helped mice that already had leukemia to survive longer.

"This was the real kicker," Majeti said. "These mice showed a profound clinical response."

The next step for the researchers is to go forward with plans to test a similar treatment in humans.

More information

Learn more about leukemia from the American Cancer Society.

SOURCE: Stanford University, news release, July 23, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com